Acuta Capital Erasca Bets Big on Targeted Cancer Therapies
A niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
Understand how zero based budgeting stacks up against traditional monthly methods and which approach best suits your financial goals.
18,282 articlesA niche investment move places acuta capital erasca (eras) at the center of Erasca's ambitious quest in targeted canc...
SpaceX is positioning Starship V3 as the backbone of an IPO that could redefine private markets. Analysts say the nex...
SpaceX IPO chatter has investors buzzing about windfalls for insiders and thousands of workers with equity. This repo...
As copper markets gyrate in 2026, investors must choose between COPX miners and CPER futures for exposure. The decisi...
Two chipmakers lit up the market in the first half of 2026, but the big question remains: which is the smarter buy no...
As markets wobble in mid-2026, a trio of NYSE dividend names stands out for safety and income. They combine durable c...
Biotech investing often feels unpredictable. This year, agios stock down year highlights how big investor moves and l...
Managed futures ETFs offer a path to diversification when risks rise across markets. This guide explains how they wor...
MercadoLibre fell in February amid margin concerns and tougher competition in LATAM. This article breaks down the for...
Quantum computing promises a new tech frontier, but today's stock prices often reflect dreams more than cash flow. Th...
The Trade Desk has faced a tough stretch, but patient investors are asking if the trade desk stock finally offers a p...
A major insider purchase often sparks questions about a stock's future. This breakdown examines what the 125,000-shar...